News, musings and commentary on dietary supplements & pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though)
Friday, May 03, 2013
Cancer drug Avastin tied to cases of flesh-eating disease in Canada
The cancer-treatment drug Avastin has been linked to 52 cases of flesh-eating disease worldwide, including one that resulted in death in Canada.
Health Canada issued a warning in conjunction with the drug's manufacturer, Hoffmann-La Roche Ltd., echoing an earlier one from the U.S. Food and Drug Administration. It offered no specific details on two Canadian cases.
People who have diabetes or cancer have a greater risk of developing necrotizing fasciitis because their immune system responses are lowered.
The FDA issued a similar warning in mid-March, indicating that cases have mainly been seen in people who had wound-healing complications, gastrointestinal perforations or fistulas.